LSK BioPartners, Inc.
Formerly Lifecord International USA, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
LSK BioPartners, Inc. chose not to state its revenue in its newest notice of a funding round (May 2019).
SEC Form D · May 2019
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · May 2019
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of LSK BioPartners, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Soo Whan Choi | Executive officer | May 2019 |
| Sung Chul Kim | Executive officer | May 2019 |
| Alex Kim | Director | May 2019 |
| Anton Gueth | Director | May 2019 |
| Ha Young Kim | Director | May 2019 |
| Soo Whan Choi | Director | May 2019 |
| Sung Chul Kim | Director | May 2019 |
| Weili Cheng | Director | Aug 2018 |